Table 1.
Anthropometric measurements and comorbidities of patient (ED) and control groups
| ED group (n = 214) | Control (n = 210) | p valueb | |
|---|---|---|---|
| Characteristics | |||
| Age (year)a | 60.7 ± 10.5 | 57.15 ± 10.1 | 0.061 |
| Body mass index (kg/m2)a | 28.46 ± 3.7 | 27.16 ± 3.1 | 0.062 |
| Height (cm)a | 174.11 ± 8.11 | 172.93 ± 6.93 | 0.467 |
| Weight (kg)a | 85.85 ± 10.21 | 82.09 ± 8.95 | 0.055 |
| Comorbidities | |||
| Diabetes mellitus | 83 (39%) | 65 (31%) | 0.636 |
| Dyslipidemia | 45 (21%) | 42 (20%) | 0.805 |
| Cardiac disease | 34 (16%) | 25 (12%) | 0.246 |
| Hypertension | 71 (33%) | 61 (29%) | 0.169 |
| COPD | 58 (27%) | 40 (19%) | 0.252 |
0.05 * < 0.001**
aData are mean ± standard deviation
bindependent samples t-test